{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T12:35:38Z","timestamp":1719405338728},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,8]]},"DOI":"10.7759\/cureus.13220","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T21:56:59Z","timestamp":1612821419000},"source":"Crossref","is-referenced-by-count":2,"title":["Do Benzodiazepines Impair Motor and Nonmotor Symptoms in a Sample of Parkinson\u2019s Disease Patients?"],"prefix":"10.7759","author":[{"given":"Wendy","family":"Gaztanaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Sarno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Margolesky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corneliu","family":"Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Jagid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26918","article-title":"Management of sleep disorders in Parkinson's disease and multiple system atrophy","volume":"32","author":"Videnovic A","year":"2017","unstructured":"Videnovic A. Management of sleep disorders in Parkinson's disease and multiple system atrophy. Mov Disord. 2017, 32:659-668. 10.1002\/mds.26918","journal-title":"Mov Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-014-0285-6","article-title":"Anxiety and depression in Parkinson\u2019s disease","volume":"16","author":"Djamshidian A","year":"2014","unstructured":"Djamshidian A, Friedman JH. Anxiety and depression in Parkinson\u2019s disease. Curr Treat Opt Neurol. 2014, 16:285. 10.1007\/s11940-014-0285-6","journal-title":"Curr Treat Opt Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870050404","article-title":"Sleep disorders and sleep effect in Parkinson's disease","volume":"5","author":"Factor SA","year":"1990","unstructured":"Factor SA, McAlarney T, Sanchez\u2010Ramos J. Sleep disorders and sleep effect in Parkinson's disease. Mov Disord. 1990, 5:280-285. 10.1002\/mds.870050404","journal-title":"Mov Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp160381","article-title":"Benzodiazepine use and cognitive decline in the elderly","volume":"75","author":"Picton JD","year":"2018","unstructured":"Picton JD, Marino AB, Nealy KL. Benzodiazepine use and cognitive decline in the elderly. Am J Health-Sys Pharm. 2018, 75:6. 10.2146\/ajhp160381","journal-title":"Am J Health-Sys Pharm"},{"key":"ref5","article-title":"The effects of benzodiazepines on cognition","volume":"66","author":"Stewart SA","year":"2005","unstructured":"Stewart SA. The effects of benzodiazepines on cognition. J Clin Psychiatr. 2005, 66:9-13.","journal-title":"J Clin Psychiatr"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use","volume":"18","author":"Barker MJ","year":"2004","unstructured":"Barker MJ, Barker M, Greenwood K. Cognitive effects of long-term benzodiazepine use. CNS Drugs. 2004, 18:37-48.","journal-title":"CNS Drugs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-4356(01)00453-x","article-title":"Benzodiazepine use and risk of dementia: a nested case-control study","volume":"55","author":"Lagnaoui R","year":"2002","unstructured":"Lagnaoui R, B\u00e9gaud B, Moore N, et al.. Benzodiazepine use and risk of dementia: a nested case-control study. J Clin Epidemiol. 2002, 55:314-318. 10.1016\/s0895-4356(01)00453-x","journal-title":"J Clin Epidemiol"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.2165\/00023210-200317110-00004","article-title":"Benzodiazepines and risk of hip fractures in older people","volume":"17","author":"Cumming RG","year":"2003","unstructured":"Cumming RG, Le Conteur DG. Benzodiazepines and risk of hip fractures in older people. CNS Drugs. 2003, 17:825-837.","journal-title":"CNS Drugs"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults","volume":"63","author":"By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel","year":"2015","unstructured":"By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015, 63:2227-2246. 10.1111\/jgs.13702","journal-title":"J Am Geriatr Soc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(09)70769-2","article-title":"Neuropathology of non-motor features of Parkinson disease","volume":"15","author":"Dickson DW","year":"2009","unstructured":"Dickson DW, Fujishiro H, Orr C, et al.. Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat Disord. 2009, 15:S1-S5. 10.1016\/S1353-8020(09)70769-2","journal-title":"Parkinsonism Relat Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/1756285613495723","article-title":"Anxiety in Parkinson\u2019s disease: identification and management","volume":"7","author":"Chen JJ","year":"2014","unstructured":"Chen JJ, Marsh L. Anxiety in Parkinson\u2019s disease: identification and management. Ther Adv Neurol Disord. 2014, 7:52-59. 10.1177\/1756285613495723","journal-title":"Ther Adv Neurol Disord"},{"key":"ref12","article-title":"Treatment of anxiety in Parkinson's disease with bromazepam","volume":"45","author":"Casacchia M","year":"1975","unstructured":"Casacchia M. Treatment of anxiety in Parkinson's disease with bromazepam. Riv Neurol. 1975, 45:326-338.","journal-title":"Riv Neurol"},{"key":"ref13","article-title":"Dramatic benefit with clonazepam treatment of intractable anxiety and panic attacks in Parkinson\u2019s disease","volume":"16","author":"Chuang C","year":"2001","unstructured":"Chuang C, Fahn S. Dramatic benefit with clonazepam treatment of intractable anxiety and panic attacks in Parkinson\u2019s disease. Mov Disord. 2001, 16:35.","journal-title":"Mov Disord"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-015-7947-5","article-title":"Association between antidepressants and falls in Parkinson\u2019s disease","volume":"263","author":"Martinez-Ramirez D","year":"2016","unstructured":"Martinez-Ramirez D, Giugni JC, Almeida L. Association between antidepressants and falls in Parkinson\u2019s disease. J Neurol. 2016, 263:76-82. 10.1007\/s00415-015-7947-5","journal-title":"J Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes AJ","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatr. 1992, 55:181-184. 10.1136\/jnnp.55.3.181","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.39.4.557","article-title":"Cognitive impairments associated with early Parkinson's disease","volume":"39","author":"Levin BE","year":"1989","unstructured":"Levin BE, Llabre MM, Weiner WJ. Cognitive impairments associated with early Parkinson's disease. Neurology. 1989, 39:557-557. 10.1212\/wnl.39.4.557","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1983.01790060110016","article-title":"The mini-mental state examination","volume":"40","author":"Folstein MF","year":"1983","unstructured":"Folstein MF, Robins LN, Helzer JE. The mini-mental state examination. Arch Gen Psychiatr. 1983, 40:812-812. 10.1001\/archpsyc.1983.01790060110016","journal-title":"Arch Gen Psychiatr"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1017\/s1355617700677032","article-title":"Category fluency test: normative data for English-and Spanish-speaking elderly","volume":"6","author":"Acevedo A","year":"2000","unstructured":"Acevedo A,  Loewenstein D, Barker W, et al.. Category fluency test: normative data for English-and Spanish-speaking elderly. J Int Neuropsychol Soc. 2000, 6:760-769. 10.1017\/s1355617700677032","journal-title":"J Int Neuropsychol Soc"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.41.3.365","article-title":"Visuospatial impairment in Parkinson's disease","volume":"41","author":"Levin B","year":"1991","unstructured":"Levin B, Llabre MM, S. Reisman S, Weiner WJ, Sanchez-Ramos J, Singer C, Brown MC. Visuospatial impairment in Parkinson's disease. Neurology. 1991, 41:365-365. 10.1212\/wnl.41.3.365","journal-title":"Neurology"},{"key":"ref20","article-title":"CVLT: California Verbal Learning Test - Adult Version: Manual","author":"Delis DC","year":"1987","unstructured":"Delis DC, Kramer JH, Kaplan E, Ober BA. CVLT: California Verbal Learning Test - Adult Version: Manual. Psychological Corporation, San Antonio; 1987."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000180516.69442.95","article-title":"Cognitive profile of patients with newly diagnosed Parkinson disease","volume":"65","author":"Muslimovi\u0107 D","year":"2005","unstructured":"Muslimovi\u0107 D. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology. 2005, 65:1239-1245. 10.1212\/01.wnl.0000180516.69442.95","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society\u2010sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS\u2010UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz CG","year":"2008","unstructured":"Goetz CG, Tilley B, Shaftman SR, et al. . Movement Disorder Society\u2010sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS\u2010UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008, 23:2129-2170. 10.1002\/mds.22340","journal-title":"Mov Disord"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.51.11.1401","article-title":"Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory","volume":"51","author":"Levin BE","year":"1988","unstructured":"Levin BE, Llabre MM, Weiner WJ. Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory. J Neurol Neurosurg Psychiatr. 1988, 51:1401-1404. 10.1136\/jnnp.51.11.1401","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"ref24","article-title":"Manual for the Beck Anxiety Inventory","author":"Beck AT","year":"1990","unstructured":"Beck AT, Steer RA. Manual for the Beck Anxiety Inventory. Psychological Corporation, San Antonio; 1990."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3999(97)00298-5","article-title":"Psychometric evaluation of the Pittsburgh sleep quality index","volume":"45","author":"Carpenter JS","year":"1998","unstructured":"Carpenter JS, Andrykowski MA. Psychometric evaluation of the Pittsburgh sleep quality index. J Psychosom Res. 1998, 45:5-13. 10.1016\/s0022-3999(97)00298-5","journal-title":"J Psychosom Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.10.014","article-title":"Cognitive profile of non-demented Parkinson's disease: meta-analysis of domain and sex-specific deficits","volume":"60","author":"Curtis AF","year":"2018","unstructured":"Curtis AF, Masellis M, Camicioli R, Davidson H, Tierney MC. Cognitive profile of non-demented Parkinson's disease: meta-analysis of domain and sex-specific deficits. Parkinsonism Relat Disord. 2018, 60:32-42. 10.1016\/j.parkreldis.2018.10.014","journal-title":"Parkinsonism Relat Disord"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/00006205-199210000-00013","article-title":"Anterograde amnesia linked to benzodiazepines","volume":"October","author":"Mejo SL","year":"1992","unstructured":"Mejo SL. Anterograde amnesia linked to benzodiazepines. Nurse Pract. 1992, October:44-50. 10.1097\/00006205-199210000-00013","journal-title":"Nurse Pract"},{"key":"ref28","article-title":"Handbook of Psychiatric Drug Therapy","author":"Rosenbaum JF","year":"2010","unstructured":"Rosenbaum JF, Arana GW, Hyman SE, Labbate LA, Fava M. Handbook of Psychiatric Drug Therapy. Lippincott Williams & Wilkins, Philadelphia; 2010."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/43216-do-benzodiazepines-impair-motor-and-nonmotor-symptoms-in-a-sample-of-parkinsons-disease-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:26:17Z","timestamp":1707506777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/43216-do-benzodiazepines-impair-motor-and-nonmotor-symptoms-in-a-sample-of-parkinsons-disease-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,8]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.13220","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,8]]}}}